EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of prostate‐specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result

Juho Pylväläinen iD, Kirsi Talala iD, Jani Raitanen iD, Antti Rannikko iD, Anssi Auvinen iD

BJU International · 2025-05 · 135 (5) · 841-850

DOI: 10.1111/bju.16641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, online erschienen am 22.01.2025. Verfasst von Juho Pylväläinen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, HUS Diagnostic Centre, Helsinki University Hospital, Helsinki, Finland. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostate-Specific Antigen, Prostate. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Syöpäsäätiö, Helsinki University Hospital, Jane ja Aatos Erkon Säätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To assess the association between prostate‐specific antigen (PSA) density (PSAD) and prostate cancer mortality after a benign result on systematic transrectal ultrasonography (TRUS)‐guided prostate biopsy. Patients and Methods This retrospective study used data from the Finnish Randomised Study of Screening for Prostate Cancer (FinRSPC) collected between 1996 and 2020. We identified men aged 55–71 years randomised to the screening arm with PSA ≥4.0 ng/mL and a benign systematic TRUS‐guided biopsy result. The cumulative prostate cancer mortality of men stratified by a PSAD cutoff of 0.15 ng/mL/cm 3 was modelled with competing risk functions. The ability of PSAD, PSA, and base variables (age at biopsy, DRE result, socioeconomic status, 5α‐reductase inhibitor usage, family history, and Charlson Comorbidity Index (CCI)) to predict prostate cancer death was compared using c ‐statistics and a likelihood ratio test.

Results

After excluding 10 men without PSA data within 2 years of the biopsy and 65 without prostate volume data, 2276 men were eligible for inclusion in the study. A total of 50 men died from prostate cancer and 1028 from other causes during a median (interquartile range) follow‐up of 17.4 (13.2–20.9) years. The cumulative prostate cancer mortality of men with PSAD

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstate-Specific AntigenProstateHumansMaleMiddle AgedAgedRetrospective StudiesFinlandImage-Guided BiopsyEarly Detection of Cancer

Stichwörter der Autor:innen

comparative studyfollow‐upprostate biopsyprostate cancerprostate‐specific antigen density

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • Department of Radiology, HUS Diagnostic Centre, Helsinki University Hospital, Helsinki, Finland.
  • Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Cancer Society of Finland, Helsinki, Finland.
  • Faculty of Social Sciences (Health Sciences), Prostate Cancer Research Center, Tampere University, Tampere, Finland.
  • UKK Institute for Health Promotion Research, Tampere, Finland.
  • Department of Urology, Helsinki University Hospital, Helsinki, Finland.

ORCID-Profile: Juho Pylväläinen, Kirsi Talala, Jani Raitanen, Antti Rannikko, Anssi Auvinen

Förderung

  • Syöpäsäätiö
  • Helsinki University Hospital
  • Jane ja Aatos Erkon Säätiö

Zitieren

APA

Pylväläinen, J., Talala, K., Raitanen, J., Rannikko, A., & Auvinen, A. (2025). Association of prostate‐specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result. BJU International, 135(5), 841-850. https://doi.org/10.1111/bju.16641

Vancouver

Pylväläinen J, Talala K, Raitanen J, Rannikko A, Auvinen A. Association of prostate‐specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result. BJU International. 2025;135(5):841-850. doi:10.1111/bju.16641

BibTeX
@article{Pylvlinen2025,
  author = {Pylväläinen, Juho and Talala, Kirsi and Raitanen, Jani and Rannikko, Antti and Auvinen, Anssi},
  title = {Association of prostate‐specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result},
  journal = {BJU International},
  year = {2025},
  volume = {135},
  number = {5},
  pages = {841--850},
  doi = {10.1111/bju.16641}
}
Kostenlos starten →